The development and biochemical characterization of resistance to azaserine in a TA 3 ascites carcinoma.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001201:Ascites; D001377:Azaserine; D002277:Carcinoma; D009374:Neoplasms, Experimental; D012694:Serine / Q000031:analogs & derivatives
D000970:Antineoplastic Agents; D012694:Serine; D001377:Azaserine
CYTOTOXIC DRUGS/effects; NEOPLASMS/experimental; SERINE/related compounds